ArticleDermatology and therapy2026

Comparing the Efficacy and Safety of Nemolizumab Versus Anti-interleukin Monoclonal Antibody Therapies in Combination with Topical Treatments for Moderate-to-Severe Atopic Dermatitis Using Network Meta-analysis.

Andrew E Pink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.